Embedded Files
Dr. Rachna Relwani
Dr. Rachna Relwani
Endocrinologist · Specialist in Early Cardiometabolic Risk
Endocrinologist · Specialist in Early Cardiometabolic Risk
The Mission: Clarity Before Disease
I focus on identifying cardiometabolic risk early—often years before it becomes visible on standard testing.
My work began with a focus on South Asians, a group known to develop heart disease earlier and more quietly. Over time, that lens expanded. I saw the same patterns in others whose risk is not fully captured—including midlife patients and women undergoing metabolic shifts.
DesiDil was built to address this gap: to provide precise answers before disease develops.
Why This Work is Personal
This work is personal. My understanding of risk didn’t come only from training; it came from experience.
My husband was a healthy, active 44-year-old: a father, attorney, and tennis player. He had no chest pain, only nausea, before an unexpected cardiac event. That experience changed how I understood risk. It made clear how often early warning signs are missed, especially in populations where disease presents differently.
As I looked deeper, a pattern emerged:
Risk was higher than expected.
Standard tests were reassuring—until they weren’t.
There was no model designed to identify this early.
So I built what I could not find: A focused, prevention-first approach designed to identify risk while it is still preventable.
The Approach
The Approach
This work is grounded in a simple principle: Risk should be identified before it becomes obvious. We move beyond standard screenings by utilizing:
Advanced Lipids: Evaluating particle patterns and markers like ApoB and Lp(a).
Metabolic Mapping: Identifying early insulin resistance and visceral fat strain.
Clinical Context: Integrating your unique genetics, history, and trajectory.
Dr. Rachna Relwani
Board-Certified Endocrinologist
I am a specialist in early cardiometabolic risk with over 15 years of clinical practice. My career has centered on identifying early metabolic dysfunction and its connection to long-term cardiovascular health.
Education & Training
Fellowship: Albert Einstein College of Medicine (Endocrinology)
Residency: Yale Primary Care (Internal Medicine)
Medical School: University of Alabama
Distinctions
I have been recognized with multiple Top Doctor distinctions, including Castle Connolly Top Women in Medicine. Beyond clinical practice, I speak nationally on early cardiometabolic risk and teach the next generation of clinicians about metabolic disease.
What I Believe
Prevention should begin before symptoms.
Risk is not always visible on standard testing.
Context matters as much as numbers.
And clarity is more valuable than reassurance.
If you’re trying to understand your risk more precisely, before it becomes obvious, this work is designed for you.
Page updated
Report abuse